Skip to main content
SpringerLink
Log in

Psychopharmakotherapie

  • Chapter
  • First Online:
Die Dialektisch Behaviorale Therapie (DBT)

  • 3442 Accesses

Zusammenfassung

In diesem Kapitel werden die Standardtherapien der medikamentösen Behandlung von Bordeline-Patienten beschrieben. Alle anderen Indikationen und deren medikamentös-therapeutische Möglichkeiten sind in dieser Auflage den jeweiligen Einzelkapiteln zugeordnet. Die medikamentöse Therapie von Borderline-Patienten ist umstritten, Meinungen von Ärzten und Kliniken gehen oftmals auseinander. Allen gemeinsam ist die Meinung, dass eine Pharmakotherapie nur wenn unbedingt nötig und so kurz wie möglich gegeben werden soll und Psychotherapie das erste Mittel der Wahl darstellt.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 74.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  • Bernardy NC, Friedman MJ (2017) Pharmacological management of posttraumatic stress disorder. Curr Opin Psychol 14:116–121. https://doi.org/10.1016/j.copsyc.2017.01.003. Epub 2017 Jan 11

    Article  PubMed  Google Scholar 

  • Black DW, Zanarini MC, Romine A, Shaw M, Allen J, Schulz SC (2014) Comparison of low and moderate dosages of extended release quetiapine in borderline personality disorder: a randomized, double-blind, placebo-controlled trial. Am J Psychiatry 171:1174–1182

    Article  PubMed  Google Scholar 

  • De Berardis D, Marini S, Serroni N, Iasevoli F, Tomasetti C, de Bartolomeis A, Mazza M, Tempesta D, Valchera A, Fornaro M, Pompili M, Sepede G, Vellante F, Orsolini L, Martinotti G, Di Giannantonio M (2015) Targeting the noradrenergic system in posttraumatic stress disorder: a systematic review and meta-analysis of prazosin trials. Curr Drug Targets 16(10):1094–1106

    Article  PubMed  Google Scholar 

  • Dulz B, Makowski C (1999) Zur Pharmakotherapie und Pharmakaforschung bei Borderline-Patienten. PTT Persönlichkeitsstörungen Theorie Ther 3:98–110

    Google Scholar 

  • Herpertz SC, Bertsch K (2015) A new perspective on the pathophysiology of borderline personality disorder: a model of the role of oxytocin. Am J Psychiatr 172(9):840–851

    Article  PubMed  Google Scholar 

  • Herpertz, S. C., Zanarini, M., Schulz, C. S., Siever, L., Lieb, K., Möller, H. J. [WFSBP Task Force on Personality Disorders] (2007). World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of personality disorders. World J Biol Psychiatry, 8, 212–244.

    Article  PubMed  Google Scholar 

  • Hill MN, Campolongo P, Yehuda R, Patel S (2018) Integrating endocannabinoid signaling and cannabinoids into the biology and treatment of posttraumatic stress disorder. Neuropsychopharmacology 43(1):80–102. https://doi.org/10.1038/npp.2017.162. Epub 2017 Jul 26

    Article  PubMed  Google Scholar 

  • Kapfhammer HP (2017a) Akute und posttraumatische Belastungsstörung. In: Möller, HJ; Laux, G; Kapfhammer, HP (Hrsg) (2017) Psychiatrie, Psychosomatik und Psychotherapie. 5 3: Berlin: Springer-Verlag GmbH Deutschland; p. 1965–2040.

    Google Scholar 

  • Kapfhammer HP (2017b) Posttraumatische Belastungsstörung (PTBS): aktuelle Entwicklungen und Ausblick. Spektrum Psychiatr 2017(2):26–35

    Google Scholar 

  • Links PS, Steiner M, Boiago I, Irwin D (1990) Lithium therapy for borderline patients: Preliminary findings. J Personal Disord 4:173–181

    Article  Google Scholar 

  • Matsumura K, Noguchi H, Nishi D, Hamazaki K, Hamazaki T, Matsuoka YJ (2016) Effects of omega-3 polyunsaturated fatty acids on psychophysiological symptoms of post-traumatic stress disorder in accident survivors: a randomized, double-blind, placebo-controlled trial. J Affect Disord. https://doi.org/10.1016/j.jad.2016.05.054. pii: S0165-0327(16)30239-7. [Epub ahead of print]

  • Pae, CU (2008) The atypical antipsychotics olanzapine and risperidone in the treatment of posttraumatic stress disorder: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials. Int Clin Psychopharmacol 23:1–8

    Article  PubMed  Google Scholar 

  • Philipsen A, Feige B, Al Shajlawi A, Schmahl C, Bohus M, Richter H et al (2005) Increased delta power and discrepancies in objective and subjective sleep-measurements in borderline personality disorder. J Psych Res 39:489–498

    Article  Google Scholar 

  • Roepke et al (2017) Doxazosin, an alpha1-adrenergic receptor antagonist, for nightmares in patients with posttraumatic stress disorder and/or borderline personality disorder; a chart review. Pharmacopsychiatry 50(1):26–31. https://doi.org/10.1055/s-0042-107794

    Article  CAS  PubMed  Google Scholar 

  • Schredl A, Paul F, Reinhard I, Ebner-Priemer U, Schmahl C, Bohus M (2012) Sleep and dreaming in patients with borderline personality disorder. A polysomnographic study. Psych Res 200:430–436

    Article  Google Scholar 

  • Sendera M, Sendera A (2014) Chronischer Schmerz. Springer, Wien/Heidelberg

    Google Scholar 

  • Soloff PH (1998) Symptom-oriented psychopharmacology for personality disorders. J Pract Psychiatry Behav Health 4:3–11

    Article  Google Scholar 

  • Soloff PH, George A, Nathan RS, Schulz PM, Perel JM (1986) Paradoxical effects of amitriptyline in borderline patients. Am J Psychiatr 143:1603–1605

    Article  CAS  PubMed  Google Scholar 

  • Stoffers J, Völlm BA, Rücker G, Timmer A, Huband N, Lieb K (2010) Pharmacological interventions for borderline personality disorder. Cochrane Database Syst Rev 16(6):CD005653

    Google Scholar 

  • Waldinger RJ, Frank AF (1989) Transference and the vicissitudes of medication use by borderline patients. Psychiatry 52:416–427

    Article  CAS  PubMed  Google Scholar 

  • Wie Qi, Gevonden M, Shalev A (2016) Prevention of post-traumatic stress disorder after trauma: current evidence and future directions. Curr Psych Rep 18:20. https://doi.org/10.1007/s11920-015-0655-0. Published online 2016 Jan 23. PMCID: PMC4723637 PMID: 26800995

    Article  Google Scholar 

  • Yehuda R et al (2015) Post-traumatic stress disorder. Nat Rev Dis Primers 8;1:150–57

    Google Scholar 

  • Zanarini MC, Frankenburg FR, Gunderson JG (1988) Pharmacotherapy of borderline outpatients. Compr Psychiatry 29:372–378

    Article  CAS  PubMed  Google Scholar 

  • Ziegenhorn et al (2009) Clonidin improves hyperarousal in borderline personality disorder with or without posttraumatic stress disorder: a randomized double blind, placebo-controlled trial. J Clin Psychopharmacol 29(2):170–173

    Article  CAS  PubMed  Google Scholar 

Weiterführende Literatur

  • Bridler R, Häberle A, Müller ST, Cattapan K, Grohmann R, Toto S et al (2015) Psychopharmacological treatment of 2195 in-patients with borderline personality disorder: a comparison with other psychiatric disorders. Eur Neuropsychoharmacol 25:763–772

    Article  CAS  Google Scholar 

  • Herpertz SC, Matzke B (2012) Borderline Persönlichkeitsstörung. In: Herpertz SC, Schnell K, Falkai P (Hrsg) Psychotherapie in der Psychiatrie. Kohlhammer, Stuttgart, S 257–290

    Google Scholar 

  • Links PS, Ansari JY, Fazalullasha F, Shah R (2012) The relationship of personality disorders and Axis I clinical disorders. In: Widiger TA (Hrsg) The Oxford handbook of personality disorders. Oxford University Press, Oxford, S 237–259

    Google Scholar 

  • Schmahl C, Bohus M (2001) Symptomorientierte Pharmakotherapie bei Borderline-Persönlichkeitsstörung. Fortsch Neurol Psychiatr 69:310–321

    Article  CAS  Google Scholar 

  • Schmahl C, Stiglmayr C, Böhme R, Bohus M (1999) Behandlung von dissoziativen Symptomen bei Borderline Persönlichkeitsstörungen mit Naltrexon. Nervenarzt 70:262–264

    Article  CAS  PubMed  Google Scholar 

  • Stoffers JM, Völlm BA, Rücker G, Timmer A, Huband N, Lieb K (2012) Psychological therapies for people with borderline personality disorder. Cochrane Database Syst Rev Aug 15;2012(8):CD005652.

    Google Scholar 

  • Stoffers JM, Lieb K (2015) Psychopharmacotherapy for borderline personality disorder – current evidence and recent trends. Curr Psych Rep 17(1):534

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Ärztin für Allgemeinmedizin und ärztliche Psychotherapie, Trausdorf an der Wulka, Österreich

    Martina Sutor

Authors
  1. Martina Sutor
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Ärztin für Allgemeinmedizin und ärztliche Psychotherapie, Trausdorf an der Wulka, Österreich

    Martina Sutor

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Sutor, M. (2022). Psychopharmakotherapie. In: Sutor, M. (eds) Die Dialektisch Behaviorale Therapie (DBT) . Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-64627-4_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-64627-4_7

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-64108-8

  • Online ISBN: 978-3-662-64627-4

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation